Suxia Luo - Henan Cancer Hospital | 人才画像

基本信息

Career Trajectory

Bio

罗素霞，女，博士，博士生导师，主任医师，二级教授，中共党员，河南省肿瘤医院业务副院长，河南省恶性肿瘤(食管癌)临床医学研究中心主任，河南省肿瘤医院机构主任，河南省肿瘤医院I期研究中心主任。
国务院政府特殊津贴专家，全国五一劳动奖章获得者，“国之名医优秀风范奖”获得者，全国优秀科技工作者，河南省学术技术带头人，省卫生厅中青年科技创新型人才，河南省三八红旗手，河南省杰出人才基金获得者，河南省优秀医师，河南省知名专家。先后主持省级以上课题10余项，发表论文120余篇，SCI 30余篇，获省科技进步奖5项，主编、副主编专著6部。

Research Interests

Papers共 419 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Neoadjuvant Camrelizumab Plus Trastuzumab and Chemotherapy for HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma: a Single-Arm, Phase 2 Trial

Yijie Ma,Zhi Li,Chen Wei,Jian Zhang,Qiang Fu,Zhandong Zhang, Chuang Shang,Jinbang Wang,Xiangbin Wan,Bin Zhang, Yongchao Zhang,Jing Li, He Zhang,Liangyu Bie,Qingxin Xia,Suxia Luo,Ning Li

Gastric Cancerno. 4 (2025): 652-661

Cited0Views0WOSBibtex

QL1203 Vs Placebo Plus Mfolfox6 As First-Line Therapy in RAS Wild-Type, Metastatic Colorectal Cancer (mcrc): Interim Analysis (IA) of a Multicenter, Randomized, Double-Blinded, Parallel, Phase 3 Trial

Weijian Guo, Yusheng Wang, Wenhui Yang, Yunfeng Li,Yanqiao Zhang,Zhongtao Zhang, Hailin Xiong, Changzheng Li,Zhiwu Wang,Nanfeng Fan,Xianli Yin,Peng Du,Suxia Luo,Jingdong Zhang,Dajun Yu,Weie Zheng,Xiaoyan Kang, Kaisheng Mao, Zhan Wang,Lin Shen

Journal of Clinical Oncology（2025）

Cited0Views0Bibtex

Efficacy and Safety of Glecirasib (JAB-21822) Monotherapy and in Combination with Cetuximab in Patients with KRAS G12C-mutated Advanced Colorectal Cancer

Jian Li, Jing Huang,Yi Ba,Baoshan Cao,Suxia Luo,Wenhua Li,Zhengbo Song,Liangjun Zhu,Jianping Xiong,Guangyu An,Yanqiao Zhang,Zhihua Li,Yongsheng Li,Yanhong Gu,XingYa Li,Chenghui Huang,Qihan Fu,Changlu Hu,Lin Shen

Journal of Clinical Oncologyno. 4_suppl (2025): 191-191

Cited0Views0Bibtex

Claudin 18.2-Targeting Antibody–drug Conjugate CMG901 in Patients with Advanced Gastric or Gastro-Oesophageal Junction Cancer (KYM901): a Multicentre, Open-Label, Single-Arm, Phase 1 Trial

Dan-Yun Ruan,Fu-Rong Liu,Xiao-Li Wei,Su-Xia Luo,Zhi-Xiang Zhuang,Zhen-Ning Wang,Fu-Nan Liu,Yan-Qiao Zhang, Jian-Wei Yang,Zhen-Dong Chen,Yong-Sheng Wang,Jun-Ye Wang,Xiao-Hua Liang,Xiao-Jie Wu,Yu-Long Zheng, Jian Liu,Xi Shi,Rakesh Kumar,Wei Liu, Bo Chen

The Lancet Oncology (2025)

Cited0Views0WOSBibtex

Anti-LAG-3 Antibody LBL-007 Plus Anti-Pd-1 Antibody Toripalimab in Advanced Nasopharyngeal Carcinoma and Other Solid Tumors: an Open-Label, Multicenter, Phase Ib/II Trial

Gang Chen, Dong-Chen Sun,Yi Ba,Ya-Xiong Zhang,Ting Zhou,Yuan-Yuan Zhao,Hong-Yun Zhao,Wen-Feng Fang,Yan Huang,Zhen Wang,Chao Deng,De-Sheng Hu, Wei Wang,Jin-Guan Lin,Gui-Ling Li,Su-Xia Luo,Zhi-Chao Fu,Hai-Sheng Zhu, Hui-Li Wang, Sheng-Li Cai,Xiao-Qiang Kang,Li Zhang,Yun-Peng Yang

Journal of Hematology & Oncologyno. 1 (2025): 1-10

Cited0Views0WOSBibtex

First-Line Pembrolizumab Plus Chemotherapy for HER2-Negative Advanced Gastric Cancer: China Subgroup Analysis of the Randomized Phase 3 KEYNOTE-859 Study

Shukui Qin,Yuxian Bai,Jin Li,Hongming Pan,Suxia Luo, Yanli Qu,Feng Ye,Lin Yang,Tianshu Liu,Wei Li,Xi Chen, Jianwei Yang,Jieer Ying,Xiaoyan Lin,Lin Zhao,Xinjun Liang,Yixiang Mao, Run Guo, Yi Zuo, Sonal Bordia, Shouguo Li

Advances in Therapyno. 4 (2025): 1892-1906

Cited0Views0WOSBibtex

PD-1 Inhibitor (sintilimab) and Fruquintinib Plus SOX As Conversion Therapy for Initially Unresectable Gastric/gastroesophageal Junction Adenocarcinoma (GC/GEJC): Updated Results from a Single-Arm, Phase 2 Clinical Trial

Fei Ma,Suxia Luo,Bin Zhang,Qi Ma,Sheqing Ji,Zhandong Zhang,Yonglei Zhang,Wei Yang,Liangqun Peng,Dandan Guo, Jinjun Ren, Yuan Zhang, Yueyue Su,Jing Li,Wentao Liu, Jinxi Huang, Weiwei Yuan

Journal of Clinical Oncologyno. 4_suppl (2025): 406-406

Cited0Views0Bibtex

Efficacy and Safety of KN026, a Bispecific Anti-Her2 Antibody, in Combination with KN046, an Anti-Ctla4/pd-l1 Antibody, in Patients with Advanced HER2-positive Nonbreast Cancer: a Combined Analysis of a Phase Ib and a Phase II Study

Dan Liu,Jifang Gong,Jian Li,Changsong Qi,Zuoxing Niu,Bo Liu,Zhi Peng,Suxia Luo,Xicheng Wang, Yakun Wang, Rusen Zhao, Lilin Chen,Ting Deng,Zhen Li,Lei Chen, Meimei Fang,Hongwei Yang,Linzhi Lu, Yanming Zhang, Fengling Kang,Ting Xu,Xiaotian Zhang,Lin Shen

Signal transduction and targeted therapyno. 1 (2025): 104-104

Cited0Views0WOSNATUREBibtex

Impact of Restrictive Versus Liberal Transfusion Strategy on Outcomes in Patients Undergoing Surgery for Spinal Metastasis: a Propensity Score-Matched Analysis

Zhehuang Li,Weitao Yao,Jiaqiang Wang,Xin Wang,Suxia Luo,Peng Zhang

Neurosurgical Reviewno. 1 (2025): 1-10

Cited0Views0WOSBibtex

Predicting Survival Outcomes in Renal Cell Carcinoma Spinal Metastases: a Multicenter Evaluation of Existing Prognostic Systems

Zhehuang Li,Feng Wei, Jinxin Hu, Youyu Zhang,Xiaoying Niu,Po Li, Xiance Tang,Weitao Yao,Suxia Luo,Peng Zhang

The spine journal official journal of the North American Spine Society (2025)

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Suxia Luo(罗素霞)

Professor

Papers共 419 篇Author StatisticsCo-AuthorSimilar Experts